Rchr
J-GLOBAL ID:201801020850829488   Update date: May. 26, 2025

Kanazawa Yoshikazu

Kanazawa Yoshikazu
Affiliation and department:
Research keywords  (2): 大腸癌 ,  胃癌
Research theme for competitive and other funds  (2):
  • 2020 - 2023 血中の腫瘍由来関連核酸検出による消化管間質腫瘍の新規治療戦略
  • 2020 - 2023 Liquid biopsy技術を加えた新たな胃癌進行度分類診断の研究
Papers (424):
  • 安藤 文彦, 柏田 建, 黒田 聖子, 朝妻 知子, 橋口 昌章, 金沢 義一, 大橋 隆治, 吉田 寛, 清家 正博, 弦間 昭彦, et al. 胃癌術後再発および肺癌免疫チェックポイント阻害剤効果予測における血中MMPとPD-1結合型可溶性PD-L1の診断的意義(Clinical significance of plasma MMPs and PD-1-binding soluble PD-L1 in gastric cancer and NSCLC treated with ICIs). 日本癌学会総会記事. 2024. 83回. J-2030
  • Fumihiko Ando, Takeru Kashiwada, Shoko Kuroda, Takenori Fujii, Ryotaro Takano, Yoshishige Miyabe, Shinobu Kunugi, Takashi Sakatani, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, et al. Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. Frontiers in Pharmacology. 2024. 15
  • Yuka Masuda, Yoshikazu Kanazawa, Osamu Goto, Daisuke Kakinuma, Kazutoshi Higuchi, Eriko Koizumi, Ryosuke Nakata, Nobuyuki Sakurazawa, Fumihiko Ando, Mikito Suzuki, et al. Primary gastric inflammatory myofibroblastic tumor treated with non-exposed endoscopic wall-inversion surgery (NEWS): A case report and literature review. DEN open. 2024. 4. 1. e243
  • Takeru Kashiwada, Ryotaro Takano, Fumihiko Ando, Shoko Kuroda, Yoshishige Miyabe, Ryuji Owada, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, et al. Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients. Frontiers in pharmacology. 2024. 15. 1384733-1384733
  • 萩原 信敏, 野村 務, 金沢 義一, 櫻澤 信行, 中田 亮輔, 安藤 文彦, 鈴木 幹人, 松谷 毅, 牧野 浩司, 吉田 寛. 食道裂孔ヘルニア・逆流性食道炎に対する当科での腹腔鏡下手術 当施設における手技のポイント. 日本消化器外科学会総会. 2023. 78回. RSV5-3
more...
MISC (521):
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page